デフォルト表紙
市場調査レポート
商品コード
1518265

ヒト細胞治療原料の世界市場レポート 2024年

Cell Therapy Human Raw Materials Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
ヒト細胞治療原料の世界市場レポート 2024年
出版日: 2024年07月22日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ヒト細胞治療原料市場規模は、今後数年で飛躍的な成長が見込まれます。2028年にはCAGR20.2%で58億6,000万米ドルに成長します。予測期間中に予想される成長は、治療用途の拡大、患者意識の高まり、有利な規制枠組み、バイオ医薬品セクターの成長、製造プロセスの改善など、いくつかの要因によるものと考えられます。予測期間に予想される主な動向には、同種療法の採用、人工知能の統合、既製細胞療法の増加、3Dバイオプリンティング技術の活用、ハイブリッド細胞療法の開発などがあります。

再生医療の採用が増加していることが、今後のヒト細胞治療原料市場の成長を促進する見通しです。再生医療は、正常な機能を回復させることを目的として、損傷した組織や臓器を修復、置換、再生するために、身体に本来備わっている再生能力を活用したり、幹細胞、組織工学、遺伝子治療などの外部刺激を用いたりすることを意味します。この分野が注目されるようになったのは、バイオテクノロジーの進歩、細胞メカニズムの理解の深まり、個別化医療に対する需要の高まり、アンメット・メディカル・ニーズにより効果的に対処できる可能性などが背景にあります。細胞療法とヒト原材料は、細胞ベースの治療に必要不可欠な生物学的成分を提供することで、様々な病状に対する標準化された信頼性の高い治療法の生産を可能にし、再生医療の普及を促進する上で極めて重要な役割を果たしています。例えば、2023年8月のAlliance for Regenerative Medicineのデータによると、世界における細胞、遺伝子、組織工学治療の開発者は大幅に増加しており、2022年第1四半期の1,369社に対し、2023年第1四半期は2,760社に達し、再生医療と先端治療に対する資金調達額は2020年の199億米ドルから2021年には227億米ドルに達すると予想されています。そのため、再生医療の導入拡大がヒト細胞治療原料市場成長の原動力となっています。

ヒト細胞治療原料市場の新興国企業は、細胞治療開発を促進するため、化学的に定義された細胞培養培地の開発にますます注力しています。細胞培養培地とは、自然環境外で細胞を試験管内で増殖・増殖させるために必要な必須栄養素、成長因子、環境条件を供給するように設計された栄養豊富な溶液です。例えば、2023年5月、スイスを拠点とするヘルスケア製造組織であるLonza Group AGは、化学的に定義された製剤、無血清・動物性成分フリーの組成、組換えタンパク質、強化された培養・展開サポート、アプリケーション支援などを特徴とするTheraPEAK T-VIVO細胞培養培地を発表し、細胞治療製造における一貫性、安全性、規制遵守を確保しました。この培地は、動物性成分を排除し、化学的に定義された製剤を採用し、規制当局に配慮した特性を取り入れることで、安全性、品質、規制遵守の向上に貢献し、技術的に大きな進歩を遂げています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のヒト細胞治療原料市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のヒト細胞治療原料市場の実績:規模と成長, 2018-2023
  • 世界のヒト細胞治療原料市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のヒト細胞治療原料市場:製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 細胞培養培地
  • 細胞培養血清
  • 細胞培養サプリメント
  • 試薬と緩衝液
  • その他の原材料
  • 世界のヒト細胞治療原料市場:細胞療法タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 樹状細胞療法
  • ナチュラルキラー(NK)細胞療法
  • 幹細胞療法
  • T細胞療法
  • 世界のヒト細胞治療原料市場:最終用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • バイオ医薬品および製薬会社
  • 受託研究機関(CRO)と受託製造機関(CMO)
  • 学術研究機関

第7章 地域別・国別分析

  • 世界のヒト細胞治療原料市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のヒト細胞治療原料市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ヒト細胞治療原料市場:競合情勢
  • ヒト細胞治療原料市場:企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • GE Healthcare
    • Corning Incorporated

第31章 その他の大手企業と革新的企業

  • Lonza Group Ltd.
  • Grifols S.A.
  • WuXi AppTec
  • Catalent Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories Inc.
  • Pall Corporation
  • Bio-Techne Corporation
  • Miltenyi Biotec
  • Actylis
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Vericel Corporation
  • ACROBiosystems

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18310

Cell therapy human raw materials encompass biological substances derived from human sources, including cells, tissues, and blood components, utilized as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials play crucial roles in various stages of cell therapy production aimed at creating treatments for diseases such as cancer, genetic disorders, and degenerative conditions.

The primary product types of cell therapy human raw materials include cell culture media, cell culture serum, cell culture supplements, reagents and buffers, and others. Cell culture media are solutions designed to provide nutrients and an optimal environment for cell growth outside their natural setting, which is essential for laboratory-based cell studies. These products find application in various types of cell therapies, including dendritic cell therapy, natural killer (NK) cell therapy, stem cell therapy, and T-cell therapy. End users encompass biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), as well as academic and research institutions.

The cell therapy human raw materials market research report is one of a series of new reports from The Business Research Company that provides cell therapy human raw materials market statistics, including cell therapy human raw materials industry global market size, regional shares, competitors with an cell therapy human raw materials market share, detailed cell therapy human raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy human raw materials industry. This cell therapy human raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy human raw materials market size has grown exponentially in recent years. It will grow from $2.34 billion in 2023 to $2.81 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth observed during the historical period can be attributed to several factors, including the increasing prevalence of chronic diseases, a rising geriatric population, high demand for regenerative medicines, governmental funding and support, and growing healthcare expenditure.

The cell therapy human raw materials market size is expected to see exponential growth in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The anticipated growth in the forecast period can be attributed to several factors, including expanding therapeutic applications, rising patient awareness, favorable regulatory frameworks, a growing biopharmaceutical sector, and improved manufacturing processes. Major trends expected in the forecast period include the adoption of allogeneic therapies, the integration of artificial intelligence, an increase in off-the-shelf cell therapies, the utilization of 3D bioprinting technology, and the development of hybrid cell therapies.

The increasing adoption of regenerative medicine is poised to propel the growth of the cell therapy human raw materials market in the future. Regenerative medicine entails leveraging the body's inherent regenerative capacities or employing external stimuli such as stem cells, tissue engineering, or gene therapy to repair, replace, or regenerate damaged tissues and organs, with the aim of restoring normal function. This field gains prominence due to advancements in biotechnology, a deepening understanding of cellular mechanisms, a rising demand for personalized medicine, and its potential to address unmet medical needs more effectively. Cell therapy and human raw materials play a pivotal role in facilitating the growing adoption of regenerative medicine by providing the essential biological components required for cell-based therapies, thereby enabling the production of standardized and dependable treatments for various medical conditions. For instance, data from the Alliance for Regenerative Medicine in August 2023 indicated a significant increase in cell, gene, and tissue-engineering therapeutic developers worldwide, reaching 2,760 in Q1 2023 compared to 1,369 in Q1 2022, with financing for regenerative medicine and advanced therapies expected to reach $22.7 billion in 2021, up from $19.9 billion in 2020. Therefore, the rising adoption of regenerative medicine is a driving force behind the growth of the cell therapy human raw materials market.

Leading companies in the cell therapy human raw materials market are increasingly focusing on the development of chemically defined cell culture media to expedite cell therapy development. A cell culture medium is a nutrient-rich solution designed to furnish essential nutrients, growth factors, and environmental conditions necessary for the in vitro growth and propagation of cells outside their natural environment. For example, in May 2023, Lonza Group AG, a Switzerland-based healthcare manufacturing organization, introduced the TheraPEAK T-VIVO Cell Culture Medium, featuring a chemically defined formulation, serum-free and animal component-free composition, recombinant proteins, enhanced culture and expansion support, and application assistance, ensuring consistency, safety, and regulatory compliance in cell therapy manufacturing. This medium represents significant technological advancements by eliminating animal components, adopting a chemically defined formulation, and incorporating regulatory-friendly characteristics, thereby contributing to improved safety, quality, and regulatory compliance.

In January 2022, Thermo Fisher Scientific Inc., a US-based scientific research and laboratory services company, completed the acquisition of PeproTech Inc. for $1.85 billion. This strategic acquisition expands Thermo Fisher's recombinant protein portfolio, aligns with its biosciences business, and strengthens its market position, impacting the cell therapy human raw materials market by enhancing product offerings and market capabilities. PeproTech Inc. is a US-based biotechnology company specializing in manufacturing products for life science research, including cytokines, antibodies, and cell culture media.

Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.

North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell therapy human raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell therapy human raw materials market consists of sales of primary cells, stem cell banks, tissue scaffolds, cryopreservation media, cell separation products, and extracellular matrices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Human Raw Materials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy human raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy human raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy human raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Cell Culture Media; Cell Culture Sera; Cell Culture Supplements; Reagents And Buffers; Other Raw Materials
  • 2) By Type Of Cell Therapy: Dendritic Cell Therapy; Natural Killer (NK) Cell Therapy; Stem Cell Therapy; T-Cell Therapy
  • 3) By End-Use: Biopharmaceutical And Pharmaceutical Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs); Academic And Research Institutions
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE Healthcare; Corning Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Therapy Human Raw Materials Market Characteristics

3. Cell Therapy Human Raw Materials Market Trends And Strategies

4. Cell Therapy Human Raw Materials Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell Therapy Human Raw Materials Market Size and Growth

  • 5.1. Global Cell Therapy Human Raw Materials Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell Therapy Human Raw Materials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell Therapy Human Raw Materials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Therapy Human Raw Materials Market Segmentation

  • 6.1. Global Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Culture Media
  • Cell Culture Sera
  • Cell Culture Supplements
  • Reagents And Buffers
  • Other Raw Materials
  • 6.2. Global Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dendritic Cell Therapy
  • Natural Killer (NK) Cell Therapy
  • Stem Cell Therapy
  • T-Cell Therapy
  • 6.3. Global Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceutical And Pharmaceutical Companies
  • Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs)
  • Academic And Research Institutions

7. Cell Therapy Human Raw Materials Market Regional And Country Analysis

  • 7.1. Global Cell Therapy Human Raw Materials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell Therapy Human Raw Materials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Therapy Human Raw Materials Market

  • 8.1. Asia-Pacific Cell Therapy Human Raw Materials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Therapy Human Raw Materials Market

  • 9.1. China Cell Therapy Human Raw Materials Market Overview
  • 9.2. China Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Therapy Human Raw Materials Market

  • 10.1. India Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Therapy Human Raw Materials Market

  • 11.1. Japan Cell Therapy Human Raw Materials Market Overview
  • 11.2. Japan Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Therapy Human Raw Materials Market

  • 12.1. Australia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Therapy Human Raw Materials Market

  • 13.1. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Therapy Human Raw Materials Market

  • 14.1. South Korea Cell Therapy Human Raw Materials Market Overview
  • 14.2. South Korea Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Therapy Human Raw Materials Market

  • 15.1. Western Europe Cell Therapy Human Raw Materials Market Overview
  • 15.2. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Therapy Human Raw Materials Market

  • 16.1. UK Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Therapy Human Raw Materials Market

  • 17.1. Germany Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Therapy Human Raw Materials Market

  • 18.1. France Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Therapy Human Raw Materials Market

  • 19.1. Italy Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Therapy Human Raw Materials Market

  • 20.1. Spain Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Therapy Human Raw Materials Market

  • 21.1. Eastern Europe Cell Therapy Human Raw Materials Market Overview
  • 21.2. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Therapy Human Raw Materials Market

  • 22.1. Russia Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Therapy Human Raw Materials Market

  • 23.1. North America Cell Therapy Human Raw Materials Market Overview
  • 23.2. North America Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Therapy Human Raw Materials Market

  • 24.1. USA Cell Therapy Human Raw Materials Market Overview
  • 24.2. USA Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Therapy Human Raw Materials Market

  • 25.1. Canada Cell Therapy Human Raw Materials Market Overview
  • 25.2. Canada Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Therapy Human Raw Materials Market

  • 26.1. South America Cell Therapy Human Raw Materials Market Overview
  • 26.2. South America Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Therapy Human Raw Materials Market

  • 27.1. Brazil Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Therapy Human Raw Materials Market

  • 28.1. Middle East Cell Therapy Human Raw Materials Market Overview
  • 28.2. Middle East Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Therapy Human Raw Materials Market

  • 29.1. Africa Cell Therapy Human Raw Materials Market Overview
  • 29.2. Africa Cell Therapy Human Raw Materials Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell Therapy Human Raw Materials Market, Segmentation By Type Of Cell Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell Therapy Human Raw Materials Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Therapy Human Raw Materials Market Competitive Landscape And Company Profiles

  • 30.1. Cell Therapy Human Raw Materials Market Competitive Landscape
  • 30.2. Cell Therapy Human Raw Materials Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE Healthcare
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Corning Incorporated
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell Therapy Human Raw Materials Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd.
  • 31.2. Grifols S.A.
  • 31.3. WuXi AppTec
  • 31.4. Catalent Inc.
  • 31.5. Sartorius AG
  • 31.6. Charles River Laboratories
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Pall Corporation
  • 31.9. Bio-Techne Corporation
  • 31.10. Miltenyi Biotec
  • 31.11. Actylis
  • 31.12. STEMCELL Technologies
  • 31.13. Takara Bio Inc.
  • 31.14. Vericel Corporation
  • 31.15. ACROBiosystems

32. Global Cell Therapy Human Raw Materials Market Competitive Benchmarking

33. Global Cell Therapy Human Raw Materials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Therapy Human Raw Materials Market

35. Cell Therapy Human Raw Materials Market Future Outlook and Potential Analysis

  • 35.1 Cell Therapy Human Raw Materials Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell Therapy Human Raw Materials Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell Therapy Human Raw Materials Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer